LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Technology Platform TheraVectys utilizes proprietary lentiviral vector technology, positioning the company at the forefront of advanced immunotherapy solutions that can appeal to biotech firms and researchers seeking cutting-edge vectors for vaccine and therapeutic development.

Strategic Industry Focus Specializing in immunotherapies targeting cancer and infectious diseases, TheraVectys offers opportunities to partners involved in personalized medicine, vaccine development, and biotech companies aiming to expand their immunotherapy pipelines.

Recent Funding Strength With a recent $20 million funding round, TheraVectys demonstrates strong investor confidence, enabling potential collaborations, licensing deals, or joint ventures focused on their novel vectors and pipeline assets.

Established R&D Collaborations Being the only joint-laboratory between a private biotech and the Institut Pasteur suggests a deep foundation in virology and immunology, offering opportunities for joint research projects, licensing, or technology licensing agreements.

Growth & Expansion Potential Although currently modest in revenue, TheraVectys’ active funding, strategic alliances, and innovative pipeline indicate significant growth potential, making it an attractive partner for companies looking to invest in or acquire early-stage immunotherapy technologies.

THERAVECTYS Tech Stack

THERAVECTYS uses 8 technology products and services including jsDelivr, MySQL, Font Awesome, and more. Explore THERAVECTYS's tech stack below.

  • jsDelivr
    Content Delivery Network
  • MySQL
    Database
  • Font Awesome
    Font Scripts
  • yepnope.js
    Javascript Frameworks
  • jQuery Migrate
    Javascript Libraries
  • SWFObject
    Miscellaneous
  • Windows Server
    Operating Systems
  • FitVids.js
    Web Tools And Plugins

THERAVECTYS's Email Address Formats

THERAVECTYS uses at least 1 format(s):
THERAVECTYS Email FormatsExamplePercentage
FLast@theravectys.comJDoe@theravectys.com
44%
First.Last@theravectys.comJohn.Doe@theravectys.com
11%
FMiddleLast@theravectys.comJMichaelDoe@theravectys.com
1%
FLast@theravectys.comJDoe@theravectys.com
44%

Frequently Asked Questions

Where is THERAVECTYS's headquarters located?

Minus sign iconPlus sign iconTHERAVECTYS's main headquarters is located at 28, Rue du Docteur Roux, Paris, Île-de-France 75015, FR. The company has employees across 3 continents, including EuropeAsiaNorth America.

What is THERAVECTYS's phone number?

Minus sign iconPlus sign icon You can contact THERAVECTYS's main corporate office by phone at
+33-1-43-90-1****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is THERAVECTYS's official website and social media links?

Minus sign iconPlus sign iconTHERAVECTYS's official website is theravectys.com and has social profiles on LinkedInCrunchbase.

What is THERAVECTYS's SIC code NAICS code?

Minus sign iconPlus sign iconTHERAVECTYS's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does THERAVECTYS have currently?

Minus sign iconPlus sign iconAs of October 2025, THERAVECTYS has approximately 18 employees across 3 continents, including EuropeAsiaNorth America. Key team members include Chief Representative: A. H.Trilingual Executive Assistant To Ceo: J. L.Trilingual Executive Assistant To CEO: J. L.. Explore THERAVECTYS's employee directory with LeadIQ.

What industry does THERAVECTYS belong to?

Minus sign iconPlus sign iconTHERAVECTYS operates in the Biotechnology Research industry.

What technology does THERAVECTYS use?

Minus sign iconPlus sign iconTHERAVECTYS's tech stack includes jsDelivrMySQLFont Awesomeyepnope.jsjQuery MigrateSWFObjectWindows ServerFitVids.js.

What is THERAVECTYS's email format?

Minus sign iconPlus sign iconTHERAVECTYS's email format typically follows the pattern of FLast@theravectys.com. Find more THERAVECTYS email formats with LeadIQ.

How much funding has THERAVECTYS raised to date?

Minus sign iconPlus sign icon As of October 2025, THERAVECTYS has raised $20M in funding. The last funding round occurred on Feb 08, 2021 for $20M.

When was THERAVECTYS founded?

Minus sign iconPlus sign iconTHERAVECTYS was founded in 2005.
THERAVECTYS

THERAVECTYS

Biotechnology ResearchFrance11-50 Employees

Based in Paris and in the USA, TheraVectys is an immunotherapy company spun off from the Institut Pasteur created in 2005 by Dr. Pierre Charneau.

TheraVectys is pioneering the application of novel lentiviral vector technology to address most of unmet and critical medical needs.

By creating the only Joint-Laboratory between a private company and the Institut Pasteur in Paris, TheraVectys develops an extensive pipeline of vaccine candidates to drive the widespread treatment and prevention of cancer and infectious diseases.

Leveraging our proprietary technology platform, and the extensive virology expertise of the Institut Pasteur, TheraVectys provides a robust and highly effective transfection mechanism to elicit a potent and targeted immune response previously unseen.

Section iconCompany Overview

Headquarters
28, Rue du Docteur Roux, Paris, Île-de-France 75015, FR
Phone number
+33-1-43-90-1****
Website
theravectys.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2005
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $20M

    THERAVECTYS has raised a total of $20M of funding over 4 rounds. Their latest funding round was raised on Feb 08, 2021 in the amount of $20M.

  • $1M

    THERAVECTYS's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $20M

    THERAVECTYS has raised a total of $20M of funding over 4 rounds. Their latest funding round was raised on Feb 08, 2021 in the amount of $20M.

  • $1M

    THERAVECTYS's revenue is estimated to be in the range of $1M

Company Leadership

  • Stylized image of a person
    A. H.
    Chief Representative
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. L.
    Trilingual Executive Assistant To Ceo
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. L.
    Trilingual Executive Assistant To CEO
    Phone icon
    Mobile Phone
  • Stylized image of a person
    E. B.
    Clinical Operations Director
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. N.
    Senior Scientist / Project Leader In Vaccine Development
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    D. S.
    General Manager
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. T.
    Senior Researcher In Car-T Cell Oncology Therapy, Project Manager
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. C.
    General Manager
    Phone icon
    Mobile Phone
  • Stylized image of a person
    G. P.
    Board Member
    Phone icon
    Mobile Phone
  • Stylized image of a person
    F. L. C.
    Ingénieur Recherche/Développement
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.